Healthcare

When cancer specialists embrace – and when they avoid – this revolutionary drug class.

A monthly dispatch of Ipsos’ best insights on the U.S., tailored for the world.

Global mental health continues to decline despite rising awareness

Practical considerations for synthetic data in healthcare market research.

GLP-1 therapies have redefined what obesity pharmacotherapy can achieve, but efficacy is no longer the only battleground.

Football, Pride, Digital Twins… Ipsos Update explores the latest research and thinking on key topics from Ipsos teams around the world.

The U.S. healthcare claims system is a reputable source of secondary real-world data, but what happens when the patient falls out of the system?

What Patients Need Next and Who Will Deliver It

In this Ipsos Point of View, discover how to harness AI's speed without falling into the confidence trap.